• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19: the new challenge for rheumatologists.

作者信息

Ferro Francesco, Elefante Elena, Baldini Chiara, Bartoloni Elena, Puxeddu Ilaria, Talarico Rosaria, Mosca Marta, Bombardieri Stefano

机构信息

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

Rheumatology Unit, Department of Medicine, University of Perugia, Italy.

出版信息

Clin Exp Rheumatol. 2020 Mar-Apr;38(2):175-180. doi: 10.55563/clinexprheumatol/r3k9l6. Epub 2020 Mar 24.

DOI:10.55563/clinexprheumatol/r3k9l6
PMID:32207680
Abstract
摘要

相似文献

1
COVID-19: the new challenge for rheumatologists.新型冠状病毒肺炎：风湿病学家面临的新挑战。
Clin Exp Rheumatol. 2020 Mar-Apr;38(2):175-180. doi: 10.55563/clinexprheumatol/r3k9l6. Epub 2020 Mar 24.
2
SARS-CoV-2: Viral Mechanisms and Possible Therapeutic Targets - What to Learn from Rheumatologists.严重急性呼吸综合征冠状病毒2：病毒机制及可能的治疗靶点——风湿病学家能提供的经验教训
J Rheumatol. 2020 Oct 1;47(10):1588-1589. doi: 10.3899/jrheum.200657. Epub 2020 May 25.
3
Reply to Rheumatologists' perspective on coronavirus disease 19: is heparin the dark horse for COVID-19?对风湿病学家关于冠状病毒病19的观点的回应：肝素会是治疗COVID-19的黑马吗？
Clin Rheumatol. 2020 Jul;39(7):2099-2100. doi: 10.1007/s10067-020-05145-w. Epub 2020 May 9.
4
Drs. Cron and Chatham reply.克朗博士和查塔姆博士回复。
J Rheumatol. 2020 Oct 1;47(10):1590-1591. doi: 10.3899/jrheum.200679. Epub 2020 May 25.
5
Rheumatologists and Pulmonologists at Temple University Weather the COVID-19 Storm Together.天普大学的风湿病学家和肺病学家共同抵御新冠疫情风暴。
J Rheumatol. 2020 Nov 1;47(11):1723. doi: 10.3899/jrheum.200740. Epub 2020 Jun 8.
6
How and why are rheumatologists relevant to COVID-19?风湿病学家与新冠病毒疾病有怎样的关联，原因又是什么？
Joint Bone Spine. 2020 Jul;87(4):279-280. doi: 10.1016/j.jbspin.2020.04.006. Epub 2020 Apr 30.
7
Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline.羟氯喹在预防新型冠状病毒感染方面的争议使风湿病学家站在了前沿。
RMD Open. 2020 Oct;6(3). doi: 10.1136/rmdopen-2020-001323.
8
Hydroxychloroquine: A Potential Ethical Dilemma for Rheumatologists during the COVID-19 Pandemic.羟氯喹：COVID-19大流行期间风湿病学家面临的潜在伦理困境。
J Rheumatol. 2020 Jun 1;47(6):783-786. doi: 10.3899/jrheum.200369. Epub 2020 Apr 2.
9
Hope.希望。
Ann Rheum Dis. 2020 Jul;79(7):986. doi: 10.1136/annrheumdis-2020-217666. Epub 2020 Apr 27.
10
COVID-19-Associated Encephalopathy and Cytokine-Mediated Neuroinflammation.新型冠状病毒肺炎相关脑病与细胞因子介导的神经炎症
Ann Neurol. 2020 Oct;88(4):860-861. doi: 10.1002/ana.25855. Epub 2020 Aug 14.

引用本文的文献

1
[Recommendations for rheumatologists on pharmacological management during the COVID-19 health emergency: Expert group opinion].[COVID-19 健康紧急状态下风湿病学家药物治疗管理建议：专家组意见]
Rev Colomb Reumatol. 2021 Apr-Jun;28(2):134-140. doi: 10.1016/j.rcreu.2020.05.021. Epub 2020 Jun 26.
2
Baricitinib and Pulse Steroids Combination Treatment in Hyperinflammatory COVID-19: A Rheumatological Approach in the Intensive Care Unit.巴瑞替尼联合脉冲激素治疗 COVID-19 超高炎症反应：重症监护室中的风湿学治疗方法。
Int J Mol Sci. 2024 Jul 2;25(13):7273. doi: 10.3390/ijms25137273.
3
One Virus, Two Diseases: Evaluation of Clinical and Immunological Differences in Covid-19 and Multisystem Inflammatory Syndrome Cases.
一种病毒，两种疾病：新冠病毒感染和多系统炎症综合征病例的临床及免疫学差异评估
Sisli Etfal Hastan Tip Bul. 2024 Apr 5;58(1):82-90. doi: 10.14744/SEMB.2023.23316. eCollection 2024.
4
Effect of traditional therapeutics on prevalence and clinical outcomes of coronavirus disease 2019 in Chinese patients with autoimmune diseases.传统疗法对中国自身免疫性疾病患者2019冠状病毒病患病率及临床结局的影响
J Transl Autoimmun. 2023 Dec 12;8:100227. doi: 10.1016/j.jtauto.2023.100227. eCollection 2024 Jun.
5
Adaptive Immunity to Viruses: What Did We Learn from SARS-CoV-2 Infection?病毒的适应性免疫：我们从 SARS-CoV-2 感染中学到了什么？
Int J Mol Sci. 2022 Nov 12;23(22):13951. doi: 10.3390/ijms232213951.
6
Common bone marrow signature in COVID-19-associated multisystem inflammatory syndrome in children: A first-wave small case series experience.儿童 COVID-19 相关多系统炎症综合征的常见骨髓特征：第一波小病例系列经验。
Pediatr Blood Cancer. 2022 Nov;69(11):e29919. doi: 10.1002/pbc.29919. Epub 2022 Aug 20.
7
Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients.抗风湿药物可能改善类风湿关节炎患者COVID-19的临床病程及结局。
Mediterr J Rheumatol. 2022 Mar 31;33(1):68-74. doi: 10.31138/mjr.33.1.68. eCollection 2022 Mar.
8
Safety and efficacy of colchicine in COVID-19 patients: A systematic review and meta-analysis of randomized control trials.秋水仙碱治疗 COVID-19 患者的安全性和有效性：随机对照试验的系统评价和荟萃分析。
PLoS One. 2022 Apr 5;17(4):e0266245. doi: 10.1371/journal.pone.0266245. eCollection 2022.
9
COVID-19: autoimmunity, multisystemic inflammation and autoimmune rheumatic patients.COVID-19：自身免疫、多系统炎症和自身免疫性风湿病患者。
Expert Rev Mol Med. 2022 Mar 15;24:e13. doi: 10.1017/erm.2022.10.
10
Colchicine Against SARS-CoV-2 Infection: What is the Evidence?秋水仙碱抗新型冠状病毒2感染：证据有哪些？
Rheumatol Ther. 2022 Apr;9(2):379-389. doi: 10.1007/s40744-022-00425-0. Epub 2022 Feb 2.